ORAMED PHARMACEUTICALS INC. Other Comprehensive Income (Loss), Net of Tax
ORAMED PHARMACEUTICALS INC. (ORMP) reported Other Comprehensive Income (Loss), Net of Tax of $301.00 thousand for the 12-month period ending 2018-08-31, per its 10-K filed 2019-11-27.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2019-11-27
- ORAMED PHARMACEUTICALS INC. other comprehensive income (loss), net of tax for the quarter ending 2018-08-31 was $504.00K.
- ORAMED PHARMACEUTICALS INC. other comprehensive income (loss), net of tax for the quarter ending 2018-05-31 was -$115.00K, a 140.21% decline year-over-year.
- ORAMED PHARMACEUTICALS INC. other comprehensive income (loss), net of tax for the quarter ending 2018-02-28 was -$414.00K, a 346.43% decline year-over-year.
- ORAMED PHARMACEUTICALS INC. other comprehensive income (loss), net of tax for the quarter ending 2017-11-30 was $326.00K.
- ORAMED PHARMACEUTICALS INC. other comprehensive income (loss), net of tax for fiscal 2018 was $301.00K, a 2.03% increase from fiscal 2017.
- ORAMED PHARMACEUTICALS INC. other comprehensive income (loss), net of tax for fiscal 2017 was $295.00K.
- ORAMED PHARMACEUTICALS INC. other comprehensive income (loss), net of tax for fiscal 2016 was -$452.00K, a 526.42% decline from fiscal 2015.
- ORAMED PHARMACEUTICALS INC. other comprehensive income (loss), net of tax for fiscal 2015 was $106.00K, a 28.38% decline from fiscal 2014.
| Period end | Other Comprehensive Income (Loss), Net of Tax 3 month | Other Comprehensive Income (Loss), Net of Tax 3 month as first filed | Other Comprehensive Income (Loss), Net of Tax 6 month | Other Comprehensive Income (Loss), Net of Tax 6 month as first filed | Other Comprehensive Income (Loss), Net of Tax 9 month | Other Comprehensive Income (Loss), Net of Tax 9 month as first filed | Other Comprehensive Income (Loss), Net of Tax 12 month | Other Comprehensive Income (Loss), Net of Tax 12 month as first filed | Other Comprehensive Income (Loss), Net of Tax 65 month | Other Comprehensive Income (Loss), Net of Tax 131 month | Other Comprehensive Income (Loss), Net of Tax 134 month | Other Comprehensive Income (Loss), Net of Tax 140 month | Other Comprehensive Income (Loss), Net of Tax 143 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2018-08-31 | $504.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-11-27 | $389.00K derived: sum of 2 quarters · filed 2019-11-27 | -$25.00K derived: sum of 3 quarters · filed 2019-11-27 | $301.00K 10-K · filed 2019-11-27 | |||||||||
| 2018-05-31 | -$115.00K 10-Q · filed 2019-07-10 | -$529.00K derived: sum of 2 quarters · filed 2019-07-10 | -$203.00K 10-Q · filed 2019-07-10 | -$299.00K derived: sum of 4 quarters · filed 2019-11-27 | |||||||||
| 2018-02-28 | -$414.00K 10-Q · filed 2019-04-10 | -$88.00K 10-Q · filed 2019-04-10 | -$184.00K derived: sum of 3 quarters · filed 2019-11-27 | $102.00K derived: sum of 4 quarters · filed 2019-11-27 | |||||||||
| 2017-11-30 | $326.00K 10-Q · filed 2019-01-14 | $230.00K derived: sum of 2 quarters · filed 2019-11-27 | $516.00K derived: sum of 3 quarters · filed 2019-11-27 | $684.00K derived: sum of 4 quarters · filed 2019-11-27 | |||||||||
| 2017-08-31 | -$96.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-11-27 | $190.00K derived: sum of 2 quarters · filed 2019-11-27 | $358.00K derived: sum of 3 quarters · filed 2019-11-27 | $295.00K 10-K · filed 2019-11-27 | |||||||||
| 2017-05-31 | $286.00K 10-Q · filed 2018-07-12 | -$286.00K 10-Q · filed 2017-07-06 | $454.00K derived: sum of 2 quarters · filed 2018-07-12 | $391.00K 10-Q · filed 2018-07-12 | -$391.00K 10-Q · filed 2017-07-06 | -$305.00K derived: sum of 4 quarters · filed 2018-11-28 | |||||||
| 2017-02-28 | $168.00K 10-Q · filed 2018-04-09 | $105.00K 10-Q · filed 2018-04-09 | -$591.00K derived: sum of 3 quarters · filed 2018-11-28 | -$675.00K derived: sum of 4 quarters · filed 2018-11-28 | |||||||||
| 2016-11-30 | -$63.00K 10-Q · filed 2018-01-11 | $63.00K 10-Q · filed 2017-01-11 | -$759.00K derived: sum of 2 quarters · filed 2018-11-28 | -$843.00K derived: sum of 3 quarters · filed 2018-11-28 | -$765.00K derived: sum of 4 quarters · filed 2018-11-28 | ||||||||
| 2016-08-31 | -$696.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-28 | -$780.00K derived: sum of 2 quarters · filed 2018-11-28 | -$702.00K derived: sum of 3 quarters · filed 2018-11-28 | -$452.00K 10-K · filed 2018-11-28 | |||||||||
| 2016-05-31 | -$84.00K 10-Q · filed 2017-07-06 | $84.00K 10-Q · filed 2016-07-06 | -$6.00K derived: sum of 2 quarters · filed 2017-07-06 | $244.00K 10-Q · filed 2017-07-06 | -$244.00K 10-Q · filed 2016-07-06 | $795.00K derived: sum of 4 quarters · filed 2017-11-29 | |||||||
| 2016-02-29 | $78.00K 10-Q · filed 2016-04-06 | -$328.00K 10-Q · filed 2017-04-05 | $879.00K derived: sum of 3 quarters · filed 2017-11-29 | $942.00K derived: sum of 4 quarters · filed 2017-11-29 | |||||||||
| 2015-11-30 | $406.00K 10-Q · filed 2017-01-11 | -$406.00K 10-Q · filed 2016-01-13 | $801.00K derived: sum of 2 quarters · filed 2017-11-29 | $864.00K derived: sum of 3 quarters · filed 2017-11-29 | $871.00K derived: sum of 4 quarters · filed 2017-11-29 | ||||||||
| 2015-08-31 | $395.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-11-29 | $458.00K derived: sum of 2 quarters · filed 2017-11-29 | $465.00K derived: sum of 3 quarters · filed 2017-11-29 | $106.00K 10-K · filed 2017-11-29 | -$106.00K 10-K · filed 2015-11-25 | ||||||||
| 2015-05-31 | $63.00K 10-Q · filed 2016-07-06 | -$63.00K 10-Q · filed 2015-07-01 | $70.00K derived: sum of 2 quarters · filed 2016-07-06 | -$289.00K 10-Q · filed 2016-07-06 | $289.00K 10-Q · filed 2015-07-01 | $24.00K derived: sum of 4 quarters · filed 2016-11-25 | |||||||
| 2015-02-28 | $7.00K 10-Q · filed 2016-04-06 | -$352.00K 10-Q · filed 2016-04-06 | -$39.00K derived: sum of 3 quarters · filed 2016-11-25 | $340.00K derived: sum of 4 quarters · filed 2016-11-25 | |||||||||
| 2014-11-30 | -$359.00K 10-Q · filed 2016-01-13 | -$46.00K derived: sum of 2 quarters · filed 2016-11-25 | $333.00K derived: sum of 3 quarters · filed 2016-11-25 | $846.00K derived: sum of 4 quarters · filed 2016-11-25 | |||||||||
| 2014-08-31 | $313.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-11-25 | $692.00K derived: sum of 2 quarters · filed 2016-11-25 | $1.21M derived: sum of 3 quarters · filed 2016-11-25 | $148.00K 10-K · filed 2016-11-25 | |||||||||
| 2014-05-31 | $379.00K 10-Q · filed 2015-07-01 | -$379.01K 10-Q · filed 2014-07-14 | $892.00K derived: sum of 2 quarters · filed 2015-07-01 | -$165.00K 10-Q · filed 2015-07-01 | $164.57K 10-Q · filed 2014-07-14 | $487.08K derived: sum of 4 quarters · filed 2015-11-25 | |||||||
| 2014-02-28 | $513.00K 10-Q · filed 2015-04-03 | $512.81K 10-Q · filed 2014-04-10 | $544.00K 10-Q · filed 2015-04-03 | $543.58K 10-Q · filed 2014-04-10 | $108.08K derived: sum of 3 quarters · filed 2015-11-25 | -$4.51K derived: sum of 4 quarters · filed 2015-11-25 | $846.99K 10-Q · filed 2014-04-10 | ||||||
| 2013-11-30 | $31.00K 10-Q · filed 2015-01-08 | $30.77K 10-Q · filed 2014-01-14 | -$404.92K derived: sum of 2 quarters · filed 2015-11-25 | -$517.51K derived: sum of 3 quarters · filed 2015-11-25 | -$508.87K derived: sum of 4 quarters · filed 2015-11-25 | $334.17K 10-Q · filed 2014-01-14 | |||||||
| 2013-08-31 | -$435.92K derived: 10-K 12 month − 10-Q 9 month · filed 2015-11-25 | -$548.51K derived: sum of 2 quarters · filed 2015-11-25 | -$539.87K derived: sum of 3 quarters · filed 2015-11-25 | -$304.00K 10-K · filed 2015-11-25 | $303.40K 10-K · filed 2013-11-27 | ||||||||
| 2013-05-31 | -$112.58K 10-Q · filed 2014-07-14 | -$103.94K derived: sum of 2 quarters · filed 2014-07-14 | $131.92K 10-Q · filed 2014-07-14 | $131.92K 10-Q · filed 2013-07-17 | |||||||||
| 2013-02-28 | $8.64K 10-Q · filed 2014-04-10 | $244.51K 10-Q · filed 2014-04-10 | $244.51K 10-Q · filed 2013-04-11 | ||||||||||
| 2012-11-30 | $235.87K 10-Q · filed 2014-01-14 | ||||||||||||
| 2012-05-31 | -$15.87K 10-Q · filed 2013-07-17 | -$20.07K derived: sum of 2 quarters · filed 2013-07-17 | |||||||||||
| 2012-02-29 | -$4.21K 10-Q · filed 2013-04-11 | ||||||||||||
| 2007-08-31 | -$16.00 10-Q · filed 2014-04-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |